there is a good chance this will be bought out or partnered by big pharma..............right now market cap is $40MM and there is talk that the success of this drug should give SPHS a market cap of $250MM to $300MM that would be about $12 to $15 per share..........gotta love the biotech stocks
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.